Neoonatal Mortality: UNICEF; 2021. Available from: https://data.unicef.org/topic/child-survival/neonatal-mortality/.
Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, et al. Every newborn: progress, priorities, and potential beyond survival. Lancet. 2014;384:189–205.
Gleason CA, Juul SE. Avery’s Diseases of the Newborn, 10th ed. Elsevier; 2018.
Shim JW, Jin HS, Bae CW. Changes in survival rate for very-low-birth-weight infants in Korea: comparison with other countries. J Korean Med Sci. 2015;30:S25–34.
Helenius K, Sjors G, Shah PS, Modi N, Reichman B, Morisaki N, et al. Survival in very preterm infants: An international comparison of 10 national neonatal networks. Pediatrics. 2017;140:e20171264.
Shah PS, Lui K, Sjors G, Mirea L, Reichman B, Adams M, et al. Neonatal outcomes of very low birth weight and very preterm neonates: An international comparison. J Pediatr. 2016;177:144–52.e6.
Special report of the neonatal research network of Japan-summary of the first 10 years of the network database neonatal research network of Japan, The Japan Society for Neonatal Health and Development; 2018.
Alldred MJ, Martini AC, Patterson D, Hendrix J, Granholm A-C. Aging with down syndrome—Where are we now and where are we going? J Clin Med. 2021;10:4687.
Takeuchi C. Involvement in children with Down Syndrome with an eye on adulthood [in Japanese]. Pediatr Health Res. 2020;79:2–9.
Boghossian NS, Hansen NI, Bell EF, Stoll BJ, Murray JC, Laptook AR, et al. Survival and morbidity outcomes for very low birth weight infants with Down syndrome. Pediatrics. 2010;126:1132–40.
Kumasaka S, Yoda H, Ishida F, Mizogami M, Kodama H, Saito K, et al. Clinical characteristics of very low birth weight infants with trisomy 21 [in Japanese]. J Jpn Soc Premature Newborn Med. 2011;23:83–7.
Kawasaki H, Yamada T, Takahashi Y, Nakayama T, Wada T, Kosugi S. The short-term mortality and morbidity of very low birth weight infants with trisomy 18 or trisomy 13 in Japan. J Hum Genet. 2021;66:273–85.
International statistical classification of diseases and related health problems: World Health Organization; 2003. 10th revision: Available from: http://apps.who.int/classifications/apps/icd/icd10online2003/fr-icd.htm.
Vital statistics, the Portal Site of Official Statistics of Japan (e-Stat): the Ministry of Health, Labour and Welfare; Available from: https://www.e-stat.go.jp/en/stat-search/files?page=1&toukei=00450011&tstat=000001028897.
Kucik JE, Shin M, Siffel C, Marengo L, Correa A. Trends in survival among children with Down syndrome in 10 regions of the United States. Pediatrics. 2013;131:e27–36.
McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12:Cd004454.
Doshi H, Moradiya Y, Roth P, Blau J. Variables associated with the decreased risk of intraventricular haemorrhage in a large sample of neonates with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 2016;101:F223–9.
Condò V, Cipriani S, Colnaghi M, Bellù R, Zanini R, Bulfoni C, et al. Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants? J Matern Fetal Neonatal Med. 2017;30:1267–72.
Greene AK, Kim S, Rogers GF, Fishman SJ, Olsen BR, Mulliken JB. Risk of vascular anomalies with Down syndrome. Pediatrics. 2008;121:e135–40.
Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down’s syndrome. Lancet. 2000;355:165–9.
Corsi MM, Dogliotti G, Pedroni F, Galliera E, Malavazos AE, Villa R, et al. Adipocytokines in Down’s syndrome, an atheroma-free model: role of adiponectin. Arch Gerontol Geriatr. 2009;48:106–9.
Movsas TZ, Spitzer AR, Gewolb IH. Trisomy 21 and risk of retinopathy of prematurity. Pediatrics. 2015;136:e441–7.
Cua CL, Blankenship A, North AL, Hayes J, Nelin LD. Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatr Cardiol. 2007;28:250–4.
Cua CL, Haque U, Miao Y, Backes CH. Necrotizing enterocolitis incidence, characteristics, and outcomes in neonatal Down syndrome patients. Am J Perinatol. 2017;34:1368–74.
Head E, Phelan MJ, Doran E, Kim RC, Poon WW, Schmitt FA, et al. Cerebrovascular pathology in Down syndrome and Alzheimer disease. Acta Neuropathol Commun. 2017;5:93.
Wilcock DM, Schmitt FA, Head E. Cerebrovascular contributions to aging and Alzheimer’s disease in Down syndrome. Biochim Biophys Acta. 2016;1862:909–14.
Santoro SL, Steffensen EH. Congenital heart disease in Down syndrome – a review of temporal changes. J Congenit Cardiol. 2021;5:1.
留言 (0)